Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bayer | Varsavia | Salute | Prodotti farmaceutici | 86,40 Mrd PLN | -22,6x | 0,1 | 88,43 PLN | 2,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Krka. Tovarna Zdravil. D.D. Novo | Varsavia | Salute | Prodotti farmaceutici | 18,44 Mrd PLN | 13,2x | 0,49 | 604 PLN | -0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Neuca | Varsavia | Salute | Prodotti farmaceutici | 3,47 Mrd PLN | 20,8x | 0,41 | 776 PLN | -2,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 7,2% Rialzo | Fai l’upgrade a Pro+ | |
Celon Pharma | Varsavia | Salute | Prodotti farmaceutici | 1,37 Mrd PLN | -28,8x | 0,62 | 25,75 PLN | -0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 29,5% Rialzo | Fai l’upgrade a Pro+ | |
Bioceltix | Varsavia | Salute | Prodotti farmaceutici | 377,21 Mln PLN | -19,5x | 2,08 | 73,40 PLN | -4,2% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 38,6% Rialzo | Fai l’upgrade a Pro+ | |
Synthaverse | Varsavia | Salute | Prodotti farmaceutici | 309,90 Mln PLN | 126,6x | -1,76 | 4,41 PLN | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Cosma | Varsavia | Salute | Prodotti farmaceutici | 66,09 Mln PLN | -2,7x | 0,01 | 0,45 PLN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Biomaxima | Varsavia | Salute | Prodotti farmaceutici | 59,54 Mln PLN | -132,7x | 1,08 | 14 PLN | -2,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Biogened | Varsavia | Salute | Prodotti farmaceutici | 55,02 Mln PLN | 10,3x | 0,23 | 22,40 PLN | -13,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Cannabis Poland SA | Varsavia | Salute | Prodotti farmaceutici | 23,42 Mln PLN | -15,6x | 1,28 | 0,48 PLN | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Genxone | Varsavia | Salute | Prodotti farmaceutici | 23,07 Mln PLN | -5,6x | 0,19 | 6,98 PLN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |